These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 18922244)

  • 21. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN
    J Clin Psychiatry; 2004; 65 Suppl 10():28-35. PubMed ID: 15242330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the tolerability of the newer mood stabilizers.
    Alao AO; Dewan MJ
    J Nerv Ment Dis; 2001 Jan; 189(1):60-3. PubMed ID: 11206668
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence.
    Kim Y; Wilkins KM; Tampi RR
    Drugs Aging; 2008; 25(3):187-96. PubMed ID: 18331071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders.
    Lopez-Larson M; Frazier JA
    Harv Rev Psychiatry; 2006; 14(6):285-304. PubMed ID: 17162653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
    Androsova G; Krause R; Borghei M; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Koeleman BPC; Kunz WS; Lerche H; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Sisodiya SM; Depondt C;
    Epilepsia; 2017 Oct; 58(10):1734-1741. PubMed ID: 28857179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
    Li X; Ketter TA; Frye MA
    J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel anticonvulsants: a new generation of mood stabilizers?
    Ghaemi SN; Gaughan S
    Harv Rev Psychiatry; 2000; 8(1):1-7. PubMed ID: 10824292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
    Arban R; Maraia G; Brackenborough K; Winyard L; Wilson A; Gerrard P; Large C
    Behav Brain Res; 2005 Mar; 158(1):123-32. PubMed ID: 15680200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.
    Macdonald KJ; Young LT
    CNS Drugs; 2002; 16(8):549-62. PubMed ID: 12096935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel treatments for bipolar disorder.
    Bowden CL
    Expert Opin Investig Drugs; 2001 Apr; 10(4):661-71. PubMed ID: 11281816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking the treatment paradigm for bipolar depression: the importance of long-term management.
    Baldassano CF; Ballas CA; O'Reardon JP
    CNS Spectr; 2004 Sep; 9(9 Suppl 9):11-8. PubMed ID: 15361807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of mood stabilizers in children and adolescents suffering from bipolar affective disorder].
    Green T; Shoval G; Weizman A
    Harefuah; 2005 Nov; 144(11):810-5, 821. PubMed ID: 16358659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pre-emptive analgesic efficacy study of novel antiepileptic agents gabapentin, lamotrigine and topiramate in patients undergoing major surgeries at a tertiary care hospital: a randomized double blind clinical trial.
    Bhosale UA; Yegnanarayan R; Gupta A; Shah P; Sardesai S
    J Basic Clin Physiol Pharmacol; 2017 Jan; 28(1):59-66. PubMed ID: 27487492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epilepsy in children: the evidence for new antiepileptic drugs.
    Verdru P
    Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New pharmacotherapies for pediatric seizures.
    Pellock JM
    Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513
    [No Abstract]   [Full Text] [Related]  

  • 38. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiepileptic drugs in the treatment of neuropathic pain.
    Eisenberg E; River Y; Shifrin A; Krivoy N
    Drugs; 2007; 67(9):1265-89. PubMed ID: 17547471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study.
    Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
    Seizure; 2018 Jul; 59():28-33. PubMed ID: 29730273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.